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Self-assembled α-Tocopherol 
Transfer Protein Nanoparticles 
Promote Vitamin E Delivery Across 
an Endothelial Barrier
Walter Aeschimann1, Stefanie Staats2, Stephan Kammer1, Natacha Olieric3, Jean-Marc 
Jeckelmann4, Dimitrios Fotiadis4, Thomas Netscher  5, Gerald Rimbach2, Michele Cascella6 & 
Achim Stocker  1
Vitamin E is one of the most important natural antioxidants, protecting polyunsaturated fatty acids 
in the membranes of cells. Among different chemical isoforms assimilated from dietary regimes, 
RRR-α-tocopherol is the only one retained in higher animals. This is possible thanks to α-Tocopherol 
Transfer Protein (α-TTP), which extracts α-tocopherol from endosomal compartments in liver cells, 
facilitating its distribution into the body. Here we show that, upon binding to its substrate, α-TTP 
acquires tendency to aggregation into thermodynamically stable high molecular weight oligomers. 
Determination of the structure of such aggregates by X-ray crystallography revealed a spheroidal 
particle formed by 24 protein monomers. Oligomerization is triggered by refolding of the N-terminus. 
Experiments with cultured cell monolayers demonstrate that the same oligomers are efficiently 
transported through an endothelial barrier (HUVEC) and not through an epithelial one (Caco-2). 
Discovery of a human endogenous transport protein with intrinsic capability of crossing endothelial 
tissues opens to new ways of drug delivery into the brain or other tissues protected by endothelial 
barriers.
The generic term vitamin E describes a group of eight plant-derived chromanols identified in 1922 by Evans and 
Bishop as an essential dietary fertility factor in rats1, 2. Out of all eight isoforms of vitamin E, which pass through 
the intestinal epithelium to a similar extend3, higher animals typically retain only RRR-α-tocopherol (α-Tol here-
after)4–6. α-Tol is a potent lipid-soluble antioxidant capable of protecting biological membranes from peroxyl rad-
ical damage and of promoting the repair of mechanically injured cells7–10. Retention of α-Tol in animals requires 
α-tocopherol transfer protein (α-TTP) in the liver, a cytosolic transporter of 32 kDa weight. α-TTP belongs to the 
Sec-14 like family, a protein group involved in secretion and lipid transfer11–15. α-TTP recognises and selectively 
extracts α-Tol from the endosomal fraction of the hepatocytes allowing for its transfer into the inner leaflet of the 
plasma membrane and eventually across the plasma membrane into the blood-stream16–21. Failure of this transfer 
leads to vitamin E deficiency, a malfunction that is associated with developmental failure in the vertebrate embryo 
and also in the early central nervous system22, 23. In developed organisms, low levels of α-Tol in peripheral nerves 
are associated with a neurological phenotype termed Ataxia with Vitamin E Deficiency24–27. Evidences from both 
human and animal studies suggest α-TTP as an essential protein factor for the female reproductive system28, 29. 
Detection of α-TTP in rodent uterus, placenta and in human yolk sac indicates that this protein may have a more 
general role than only delivery of α-Tol into the blood stream30, 31.
The detailed molecular mechanisms regulating α-Tol homoeostasis in the body are not fully understood. A 
hypothetical pathway from the liver to the target cell must involve the capturing of α-Tol from the late endosome 
outer leaflet and its transportation to the cytosolic facing leaflet of the plasma membrane18, 32. In recent times, two 
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independent research groups suggested that transfer of α-Tol to the plasma membrane is coupled to the extrac-
tion of phosphatidylinositolphosphates (PIPs) from the same membrane by α-TTP16, 33. Incorporation of α-Tol 
in the outer leaflet may occur by flippase activity34 or by participation of the ATP-binding cassette transporter 
ABCA117, 35. It was noticed that, after secretion, major fractions of α-Tol appear in nascent very low density 
lipoprotein in the perisinusoidal space (space of Disse)36. Incorporation of α-Tol into recipient cells is still not 
well understood. In particular, α-Tol is essential to the reproductive apparatus and the central nervous system, 
which are both protected by endothelial barriers. Appropriate mechanisms for crossing these barriers have not 
been described so far28, 37. Here we show that, upon binding to α-Tol, α-TTP is formed acquiring tendency to 
aggregation into high molecular weight oligomers. X-ray diffraction reveals a spheroidal nanoparticle formed by 
24 α-TTP protomers of ≈17 nm diameter. We verify that such particles are efficiently and selectively transported 
through a model endothelium tissue from human umbilical vein, with a 28-fold increased flux with respect to 
paracellular flux. As aggregation is facilitated by the presence of negatively charged lipids, the assembly of the 
nanoparticle may occur in vivo at the plasma membrane after interaction with PIPs, consistently with previous 
findings16.
Results
α-Tol-induced formation of α-TTP nano-cages. Freshly prepared samples of ligand-free α-TTP (apo-
α-TTP) dialysed in solutions of anionic detergent in the presence or absence of α-Tol were subjected to prepara-
tive size exclusion chromatography (SEC). In the presence of α-Tol two major peaks were obtained representing 
the ligand complexes of monomeric α-TTP and of its high molecular weight aggregates (Fig. 1A). The con-
tent of the high molecular weight SEC peak fraction S (fractions 1–9) was resolved by native gel electrophoresis 
(PAGE) revealing the presence of a sharp band of oligomeric α-TTP (α-TTPS; apparent mass 720 kDa) and of 
lower molecular weight forms of oligomeric α-TTP (Fig. 1B). Re-chromatography of the SEC peak fraction S by 
analytical SEC yielded a major peak of high molecular weight α-TTP oligomers and a minor peak representing 
monomeric α-TTP (Fig. S1). The re-appearance of monomeric α-TTP in the re-chromatography step indicated 
reversible equilibration between the states. Imaging of high molecular weight α-TTP oligomers by transmission 
electron micrography (TEM) displayed spheroidal particles with a broad Gaussian distribution of the diameter 
centred around 17.5 ± 4 nm (Fig. S1). Dynamic light scattering measurements in solution consistently reported 
a diameter of 17.6 ± 4 nm. Temperature-dependent circular dichroism spectroscopy of apo-α-TTP, α-TTP 
and α-TTPS reported an increase in the respective melting temperatures (Tm) from 51 °C to 68 °C and >90 °C, 
Figure 1. Formation of α-TTP homo-oligomers in presence of α-Tol. (A) SEC traces of apo-α-TTP 
(black trace) and α-TTP (red trace) in a preparative SEC setup. (B) Native PAGE of peak fraction S from 
preparative SEC. (C) SEC-MALS profiles of re-chromatographed peak fraction S and of monomeric α-TTP; 
the derived molar masses were 0.76 MDa ± 2.66% and 3.24 kDa ± 1.14% respectively. (D) Native PAGE of 
re-chromatographed peak fraction S after overnight incubation at room temperature in 10% v/v DMSO or 
reduction in 50 mM DTT. Disassembly of α-TTPS into lower oligomers was not observed in either case.
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indicating that the monomeric ligand complex of α-TTP is more stable than its apo-form and further stabilised 
by self-aggregation (Fig. S1F). The fraction of oligomeric α-TTPS that produced a sharp band in native PAGE was 
separated from the α-TTP oligomeric states of lower molecular weight by analytic SEC. The separated fraction 
of oligomeric α-TTPS was analysed for integrity and size by SEC coupled to multi-angle light scattering (MALS-
SEC) revealing a mass of 760 kDa ± 2.6% (Fig. 1C). Incubation of fractions of oligomeric α-TTP overnight at 
room temperature under mild oxidising conditions (10% v/v DMSO)38 or under reducing conditions (50 mM 
DTT) respectively did not evidence any re-equilibration into other states in native PAGE (Fig. 1D). It was con-
cluded that the 760 kDa peak fraction α-TTPS represents a stable, kinetically trapped form of oligomeric α-TTPS. 
The oligomeric α-TTPS forms of the 760 kDa peak fraction were exclusively observed in the α-Tol bound state. In 
the absence of α-Tol, apo-α-TTP was detected mostly in monomeric or homo-dimeric states both in preparative 
and in analytical SEC (Fig. 1A, Fig. S1).
Crystal structure of tetracosameric α-TTPS. α-TTPS crystallised exclusively when starting from mon-
odisperse solutions of monomeric α-TTP. α-TTPS can exist in different oxidation states; we obtained crystals in 
both the fully reduced and the fully oxidised states. X-ray diffraction patterns indicated that both crystals belong 
to the space group I432, with essentially identical unit-cell parameters a = 168.18 Å (reduced) and a = 168.26 Å 
(oxidised). The crystal structures were solved by molecular replacement method using the atomic model of mon-
omeric α-TTP (PDB code 1OIP39) and refined at 2.40 Å resolution (reduced form; Rwork:Rfree 18.2%:21.5%) and at 
2.42 Å resolution (oxidized form; Rwork:Rfree 19.1%:21.2%) respectively (see Table 1). In both cases, the asymmetric 
unit consists of a single α-TTP molecule (residues 48–278) with one α-Tol ligand bound to it. α-TTPS is formed 
by 24 protomers, for a molecular mass of 0.76 MDa, assembled into a spheroidal shell reminiscent of a viral capsid 
(Fig. 2). Inspection of the density map of the α-TTPS model revealed well defined density for α-Tol indicating 
that the protomers in the particle are bound to the ligand (Fig. S3). The X-ray structural model of α-TTPS, for 
both redox states, has an external diameter of 16.8 nm consistent in size with measurements on α-TTPS parti-
cles from soluble preparations (Fig. S1). The structure is further characterised by an apparently hollow cavity of 
8.1 nm diameter. Analysis of the electrostatic map at the solvent accessible surface indicates a positive potential in 
the cavity, corresponding to the localisation of the basic amino acids responsible for binding of PIPs as described 
by Arai and coworkers16. The chiral α-TTPS assembly takes the topology of a twisted cantellated cube (point 
symmetry group O, Schonflies notation) taking the centres of each protein monomer as vertexes, and connecting 
them through protein-protein contact interfaces. According to its point group, α-TTPS symmetry operations are 
proper rotations only around three C4, four C3 and six C2 axes (Fig. 2). Each α-TTP monomer is in contact with 
four first neighbours. With two of such neighbours, it forms one of the eight trimeric interfaces crossed by the C3 
symmetry axes, and with the second two neighbours it is involved in building up one of the six tetrameric inter-
faces crossed by one of the C4 axes. The tetrameric unit is completed by a second neighbour unit, which is anyway 
not in direct contact. Each tetrameric unit is characterised by an open channel of ≈21 Å width (Fig. 2). Twelve 
rhomboidal faces complete the nano cage, each crossed by one of the C2 symmetry axes. The two asymmetric 
PDB ID
α-TTPS (reduced state) α-TTPS (oxidized state)
5MUE 5MUG
Crystal parameters I432 I432
Cell dimensions a, b, c (Å) 168.18, 168.18, 168.18 168.26, 168.26, 168.26
α,β,γ (◦) 90, 90, 90 90, 90, 90
Data Collection
Wavelength, Å 0.9998 1.0079
Resolution (Å) (outer shell) 48.55–2.40 (2.54–2.40) 48.57–2.42 (2.57–2.42)
No. observations 174351 139722
No. unique reflections 16228 15731
Mean redundancy 9.31 (9.53) 11.56 (11.31)
Completeness (%) 99.7 (99.1) 98.6 (95.9)
Rmeas % 9.50 (162.1) 9.60 (134.3)
I/σ(I) 21.80 (1.54) 14.00 (1.41)
CC (1/2) 99.9 (59.9) 99.8 (52.9)
Refinement Resolution range (Å) 39.64–2.40 48.57–2.42
No. reflections working set 16229 15736
No. reflections test set 809 786
Rwork/Rfree 18.2/21.5 19.1/21.2
rms bonds, (Å) 0.002 0.003
rms angels, (◦) 0.617 0.680
Residues included 48–275 48–278
Ramachandran statistic Generously allowed, % 100 100
Not allowed, % 0 0
Table 1. Data collection and refinement statistics.
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edges of such interfaces correspond to those of the trimeric and tetrameric assemblies. Each monomer is involved 
in two of these interfaces. The oxidised form of α-TTPS presents here one disulphide bridge crosslinking C80 of 
two α-TTP units through the rhombohedral channel (Fig. 3A). The oxidised α-TTPS particle thus contains a 
total of 12 S-S bridges covalently binding all trimeric subunits. Oxidation is accompanied by local unwinding of 
the helical segment (aa’s 65–79). It also induces structuring of the neighbouring C-terminus (aa’s 275–278) into 
a regular α-helical motif (Fig. 3B). No other significant structural differences are observed between the reduced 
and oxidised forms of α-TTP.
Protein-protein interfaces. The highly packed trimeric interface is constituted by several protein-protein 
contacts. Each unit interacts with the following one through the helical segment 49–56, the 57–64 loop, and the 
first turn of the helical segment 65–79, as well as with residue R151. The partner protein interacts with the amino 
Figure 2. Atomic models of the tetracosameric assembly of α-TTPS. (A) View of the atomic model along the 
three symmetry axes; four-fold in blue (channel width ≈21 Å), three-fold in purple and two-fold in orange. 
In the centre a geometric representation of the twisted cantellated cube (TCC) with a ribbon cartoon of a 
monomer sitting on a node is shown. (B) Electrostatic maps of the tetracosameric assembly and of α-TTP; 
the outer sphere surface of the tetracosamer is mainly negatively charged (left) whereas its interior is mainly 
positively charged (middle); electrostatic maps of the external and internal faces of α-TTP (right).
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acids 67–74 in the helical segment 65–79, and with the C-terminal residues (aa’s 275 to 278) (see Fig. 4 and Table 2 
for details). The trimeric interface is characterised by hydrophobic packing and further stabilised by salt bridges. 
These electrostatic interactions are localised mostly at the exterior of the interface, with residues R57 and R151 on 
one protein interacting with the C-terminus of the facing unit. Residues D64 and K71 constitute one additional 
salt bridge (3.87 Å), localised closer to the core of the interface. At the very centre, the three W67 residues interact 
with each other in T-shape by van der Waals stacking. To our observation, this is the only contact point involving 
more than two proteins in the whole α-TTPS. W67 together with L63, F61 and L56 constitute a classical hot spot 
that accounts for roughly three quarters (77%) of the interface’s overall binding free energy40, 41 (Fig. 4A). The 
protein-protein interface at the four-fold symmetry shows a smaller area of contacts than the three-fold one. We 
observe only one moderately strong H-bond bridge (3.13 Å) between the backbone of V201 and the side-chain 
of Q235 of the adjacent subunit. Hydrophobic interactions involve F165, P200, V201 and I202 on one protomer, 
and P109, Q235 and H236 on the neighbouring one. Finally, a weak H-bond (4.04 Å may form between the 
side-chains of S208 and E220. The most prominent feature of the tetrameric interface is its intrinsic steric proper-
ties preventing the opening of the mobile gate, thus hindering substrate release (Fig. 4D).
Transcytosis of α-TTPS. We monitored the transcytotic efficacy of tetracosameric α-TTPS compared to its 
monomer form in an in vitro transwell model system comprising confluent and maturely developed monolayers 
of human umbilical vein endothelial cells (HUVECs)42 (Fig. 5). Measurements on human transferrin served as 
positive control as in previous studies43. Addition of rhodamine isothiocyanate-labeled dextran simultaneously 
confirmed the integrity of the HUVEC cell monolayers and served to determine the paracellular flux42, 43. Our 
measurements report a 28-fold and 10-fold increase in the flux through the endothelial cell layer of α-TTPS and 
α-TTP, respectively, compared to that of rhodamine isothiocyanate-labeled dextran. Our data also show that 
α-TTPS crosses the endothelium at a flux rate 9.6 times faster than human transferrin. Repetition of the experi-
ments with polarised epithelial monolayers of Caco-2 cells forming a tight barrier in the same transwell system44 
did not report any transport for either α-TTPS or α-TTP. This may suggest that the transcytotic transport mech-
anism for α-TTP might be specific to endothelial cells only which warrants further verification.
Discussion
Assembly mechanism. Crystallisation trials indicated that α-TTPS crystals grow with protein concen-
trations above 12 mg/ml regardless of the chosen condition. On the other hand, we were able to observe the 
self-assembly of α-TTPS in solution by optimising the ligand loading process in the presence of anionic deter-
gent at protein concentrations as low as 1 mg/ml of protein. Subjecting soluble preparations to preparative SEC 
revealed a peak M representing monomeric α-TTP and a peak S representing oligomeric α-TTP (see Fig. 1A). 
Figure 3. (A) Cysteine bond formation between two adjacent C80 across the rhombohedral channel along the 
two-fold symmetry axis in the oxidised form of α-TTPS. (B) Comparison of the structures in the proximity 
of the C-terminus. Monomeric α-TTP (tan); α-TTPS reduced state (pink); α-TTPS oxidised state (cyan). The 
dashed arrow highlights the large conformational change at the N-terminus (aa’s 1–47) required to expose the 
trimeric interface.
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When analysing fractions of the oligomeric α-TTP peak S by native PAGE a sharp band representing α-TTPS 
besides oligomers with aggregation number <24 and of monomeric α-TTP respectively were detected. Initially, 
we hypothesised that oligomerisation might be under the control of a reversible equilibrium between the oli-
gomeric states and monomeric α-TTP. However, when separating α-TTPS by analytical SEC from the lower 
molecular weight oligomers of α-TTP no significant re-equilibration of the former state into any other state could 
be detected by native PAGE (Fig. 1D). We interpreted these results as an evidence that mature α-TTPS particles 
represent a kinetically trapped state that does neither re-equilibrate into metastable α-TTP oligomers with aggre-
gation number <24 nor into monomeric α-TTP. It was concluded that, whenever conditions for early aggregation 
are satisfied, then the particles can rapidly develop into the final α-TTPS structure.
We also observed that apo-α-TTP in the absence of its cognate ligand is in equilibrium between monomeric, 
dimeric and tetrameric forms, but it never develops into heavier oligomers (Fig. S1A). The previously determined 
crystallographic structure of homo-dimeric apo-α-TTP shows an intercalated structure where the two mobile 
gate helices of each monomer protrude into the binding cavity of the other protein39. This protein-protein inter-
face is inconsistent with those appearing in α-TTPS, indicating that apo-dimer cannot structurally develop into 
such oligomer.
Comparison between the X-ray structures of the monomeric ligand complex α-TTP39 and α-TTPS shows that 
the overall fold is well conserved. In particular, the portion of protein surface involved in the tetrameric interface 
contacts is fully solvent exposed in α-TTP. Moreover, no structural changes occur in this area when proteins 
Figure 4. Schematic view of protein-protein interactions on the three-fold axis (A) and on the four-fold axis 
(C) (see Table 2 for details). (B) Close up view of the region around the three-fold axis. W67 forms a T-shaped 
van der Waals interaction with the adjacent homologs; this is the only point where a monomer interacts with 
two neighbours. The hydrophobic contact area of residues W67, L63, F61 and L56 defines a “hot-spot” motif 
in which binding energy is largely concentrated. (D) View from the interior along the C4 axis; the mobile gate 
moieties are coloured red to emphasise the steric hindrance is interfering with the release of α-Tol.
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2-fold symmetry axis Interface
ΔiG [kcal mol−1] Interface area [Å2] CSS
−4.80 72.10 0.091
Residue 1 Residue 2 Interaction
C80 C80 Cysteine
3-fold symmetry axis Interface
ΔiG [kcal mol−1] Interface area [Å2] CSS
−4.70 447.50 0.217
Residue 1 Residue 2 Interaction
R151 E275, Q278 Salt Bridge
R57 Q278 Salt Bridge
R57 E275 Hydrogen Bond
F61 Y74, I277, S276 vdW
L56 Y74 vdW
D64 K71 Salt Bridge
L63 K71, L70, W67 vdW
W67 W67, D64, L63 vdW
4-fold symmetry axis Interface
ΔiG [kcal mol−1] Interface area [Å2] CSS
−3.50 243.6 0.071
Residue 1 Residue 2 Interaction
P109 F165 vdW
H236 V201, I202 vdW
Q235 F165, P200, I202 vdW
Q235 V201 Hydrogen Bond
E220 S208 Hydrogen Bond
Table 2. Summary of protein-protein interactions contributing to the stability of α-TTPS. The PDBePISA84 
web-based tool was used to evaluate protein-protein interactions. ΔiG indicates the solvation free energy gain 
upon formation of the interface, in kcal/M. The value is calculated as difference in total solvation energies of 
isolated and interfacing structures. Negative ΔiG corresponds to hydrophobic interfaces, or positive protein 
affinity. This value does not include the effect of satisfied hydrogen bonds and salt bridges across the interface. 
Interface area in Å2, calculated as difference in total accessible surface areas of isolated and interfacing 
structures divided by two. CSS stands for the Complexation Significance Score, which indicates how significant 
for assembly formation the interface is. The score is defined as a maximal fraction of the total free energy of 
binding that belongs to the interface in stable assemblies.
Figure 5. (A) Flux-rates of transcytosis across a human umbilical vein endothelial cell (HUVEC) monolayer. 
(B) Flux-rates of transcytosis across a heterogeneous human epithelial colorectal adenocarcinoma cell (Caco-2) 
monolayer. Three independent experiments were performed within each cell line; n = 3, respectively.
www.nature.com/scientificreports/
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aggregate in α-TTPS. The ordered part of the trimeric interface in α-TTPS is not exposed to the solvent due to 
folding of its N-terminal segment (aa’s 25–47). Comparison of the crystal structure of the monomeric ligand 
complex of α-TTP with known structures of the different members of the Sec-14 like family evidences that the 
N-terminal segment 1–47 is s not always fully detected by X-ray scattering, it may organise in different confor-
mations45–48. This may indicate that this portion of the protein is less structured and more prone to refolding. 
Formation of trimeric assemblies requires that this region of the protein is displaced in the outer space of α-TTPS 
(Fig. 3). In our crystal structure, the 1–47 segment was not detected, probably due to conformational disorder.
The trimeric interface is wider than the tetrameric one (447 Å2, and 243 Å2, respectively) and characterised by 
a larger number of strong contact interactions (Fig. 4). Estimation of the binding energy per protein per surface 
confirms that the trimeric interface is strongly favoured with respect to the tetrameric one (∆Gbind(trimer) = 
−4.70 kcal mol−1, ∆Gbind(tetramer) = −3.50 kcal mol−1) (Table 2). Structural analysis of the protein contact sur-
faces by the ProFace server49, 50 revealed that the total trimeric interface was 862.46 Å2 and includes 4% of the 
total protein surface area of each protomer, with roughly a third (28%) being fully buried. On the contrary, the 
tetrameric interface is smaller with 464.32 Å2 and not solvent exposed for only its 12%. Surface complementa-
rity51 of the two interfaces report 0.7 and 0.62 values, respectively. Summing up these evidences, unmasking of an 
otherwise inaccessible surface area is a mandatory requirement, besides a cognate bound ligand, for efficient self- 
assembly of α-TTPS. We propose that natively folded α-TTP produces dimers and tetramers by protein-protein 
interaction through the tetrameric interface. Refolding of the 1–47 N-terminal region activates aggregation 
through the trimeric interface, which leads to more stable light molecular weight oligomers, which can rapidly 
evolve into the α-TTPS assembly.
Native PAGE experiments indicate the presence of multiple oligomeric states with aggregation number <24 
(Fig. 1B). Structural comparison between α-TTP and α-TTPS alone cannot elucidate the mechanisms of refolding 
of the N-terminal segment. In our experiment, we observe that formation of α-TTPS is facilitated by either the 
presence of sodium cholate or alternatively by high salt concentrations (i.e. [NH4SO4] = 100 mM), suggesting 
that interference of amphiphilic or charged species disturbing the N and C termini triggers the required local 
refolding. We notice that folding stabilisation of the C-terminal amino acid residues accompanies the maturation 
of α-TTPS. In the oxidised α-TTPS, it is involved in a strong H-bond and salt-bridge network of interactions with 
the partner protein (Fig. 3).
Transcytosis. Receptor-mediated entry mechanisms of macromolecules into barrier-protected tissues have 
been reported in the last decades for insulin52, immunoglobulin53, low density lipoprotein54 and ferritin55. Here 
we report for the first time the existence of a tetracosameric functional transcytotic unit of α-TTP. Very recently, 
the existence of oligomeric states functional for lipid transfer have been postulated for Sec-14 like proteins by the 
groups of Arai and Bankaitis16, 56.
In vitro measurements of transcytotic flux evidence that α-TTPS efficiently and selectively transfers mature 
HUVEC monolayers. Compared to transferrin, serving as positive control43, 57, 58, the transfer rate of α-TTPS in 
HUVEC cells is significantly (9.6-fold) faster. The choice of transferrin as positive control system is justified by 
evidences of its receptor-mediated transcytosis in a broad range of cell culture models (L-6 cells, HMVEC-d, 
HeLa, 293 T)57–60. In particular, transferrin flux rates in HUVEC cell monolayers found by us are similar to those 
measured through a bovine retinal endothelial cell (BREC) monolayer42.
Interestingly, ferritin, the iron storage protein comprising 24 monomers exerted similar flux rates in the BREC 
model as transferrin43. α-TTPS has similar topology as the 24-meric assembly of ferritin61, which is involved in 
homoeostasis of iron in the brain. The two proteins are not homologous. Thus our finding indicates convergent 
evolution towards a specific protein assembling topology that facilitates controlled endothelial crossing. Contrary 
to endothelia, α-TTPS transfer rates in human Caco-2 epithelial cells are barely detectable, indicating the exist-
ence of an efficient and directed transport system for α-TTP through endothelial cell layers. Nevertheless, a lack 
of transcytosis does not necessarily mean that Caco-2 cells do not take up TTP or export vitamin E, but puta-
tively less effectively or via other mechanisms. Grebenstein and co-workers demonstrated that in TTP knockout 
mice fed equimolar doses of α- and γ-tocopherol α-TTP knockout resulted in almost complete depletion of 
α-Tol in the brain, but not in many other tissues. These data suggest a rather tissue-specific delivery of α-Tol via 
TTP thereby maintaining α-Tol concentrations within a certain range62. On the basis of recent animal studies 
it has been proposed that α-TTP is essential for the bioavailability and the delivery of α-Tol to specific target 
sites in humans23, 63. Deletion of the α-TTP gene in mice resulted in a reduced accumulation of dietary α-Tol 
in the liver and depletion of peripheral tissue α-Tol while the brain was the organ that was affected most sig-
nificantly64. Traber and co-workers describe an α-TTP-mediated preferential enrichment of α-Tol in very low 
density lipoproteins in dependency of metabolic processes in the liver (20, 35) and the α-Tol-associated antioxi-
dative protection of neurones (23, 27). Anyway, tissue-specificity and the fascinating hypothesis of a conceivable 
receptor-mediated α-TTPS transport has to be explored by future studies using further endothelial and epithelia 
cell models mimicking different compartments of the organism.
Perspectives. By its own structure, α-TTP acquires several properties including substrate recognition and 
binding, self-assembly, auto cross-linking, and transcytotic potency. Intrinsic to the assembly, inhibition of sub-
strate release by steric blockage of the mechanism of access to the ligand binding cavity also occurs. The discovery 
of such an intrinsic ability to self-assemble into functional nano-particles paves the way to future studies deter-
mining the means by which vitamin E is physiologically trafficked through the body.
Moreover, regardless of its potential physiological role, discovery of an endogenous nano-structure featur-
ing such properties opens large perspectives towards new bio-medical/biotechnological applications. The cavity 
present in α-TTPS could in principle accommodate nucleic acids, proteins or lipid fractions of suitable size and 
www.nature.com/scientificreports/
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charge distribution. For this, potential substrates would have to be encapsulated during oligomer assembly or, 
alternatively, travel through the pores to reach the inner cavity. The eventual presence of lipids in the same cavity 
may also facilitate localisation of generic lipophilic substrates. The discovery of an endogenous transport protein 
of α-Tol having intrinsic capability of crossing endothelial cells may open to new ways of drug delivery. Finally, 
eventual identification and characterisation of a receptor for α-TTPS may lead to engineering selective entry 
pathways to specific tissues protected by endothelia such as brain, placenta or others.
Methods
Expression and Purification. The N-terminal (His)6-tagged α-TTP expression construct was made 
by cloning the PCR product derived from a human cDNA library into the NdeI and XhoI sites of the pET-
28a vector (Stratagene, CA. USA) using the primers 5′- GGGAATTCGCAGAGGCGCGATCCCAG -3′ and 
5′- CCGTCATTGAATGCTCTCAGAAATGC -3′. Protein expression was performed in Escherichia coli strain 
BL21(DE3) under control of the T7 promoter. Transformed bacteria were grown at 37 °C to an OD600 of 0.8 and 
induced with 330 µM isopropyl-thiogalactopyranoside (IPTG) overnight at 30 °C. Bacteria were harvested by cen-
trifuging at 7300 g and 4 °C for 30 minutes. Bacterial pellets obtained from one liter of medium were re-suspended 
in 25 ml lysis buffer (20 mM Tris, pH 8.0, 100 mM NaCl, 10 mM imidazole, 0.5 (v/v) Triton X-100 and 1 mM 
phenylmethylsulfonyl fluoride). Harvested cells were disrupted twice in a French pressure cell. The lysate was 
centrifuged at 39000 g and 4 °C for 40 minutes. The clarified supernatant was passed through a column containing 
12 ml of TALON Superflow (Clontech Laboratories, CA, USA). Non-specifically bound proteins were removed 
by rinsing the column with washing buffer (20 mM Tris, 100 mM NaCl, 10 mM imidazole, pH 8.0) until the UV 
absorption at 280 nm recovered the level of the base line. The protein was eluted with elution buffer (20 mM Tris, 
100 mM NaCl, 150 mM imidazole, pH 8.0). The (His)6-tag was cleaved off using thrombin (GE Healthcare, Little 
Chalfont, UK) in elution buffer (20 mM Tris, 100 mM NaCl, 150 mM imidazole, pH 8.0) at 4 °C overnight. The 
protein eluate was pooled and concentrated using Vivaspin (Sartorius, Gottingen, DE) centrifugal concentrators 
(MWCO 10 kDa) to ≤2.5 mg/ml in order to prevent aggregation of apo-α-TTP.
Preparation of α-TTP ligand-complexes. Protein-ligand complex formation was induced by dialysing 
freshly prepared apo-α-TTP in the presence of detergent solubilised α-Tol. In brief, a droplet of 1 mg of α-Tol was 
overlaid with 40.9 mg of solid sodium cholate and subsequently suspended in 1 ml of elution buffer (20 mM Tris, 
100 mM NaCl, 150 mM imidazole, pH 8.0). The suspension was bath sonicated until all material had dissolved 
to a clear solution. Apo-α-TTP (11 ml at ≤2.5 mg/ml) was complemented with the tocopherol-sodium cholate 
solution at 9:1 (v/v) ratio and transferred into a CelluSep T3 dialysis tubular membrane with an MWCO range 
of 12–14 kDa (Membranes Filtration Products. TX, USA). Dialysis was performed in two steps against 3 l buffer 
(20 mM Tris, 100 mM NaCl, pH 8.0) each for six hours at 4 °C. The dialysate (12 ml) was filtered through a Millex 
GP 0.22 µm filter (EMD Milipore, MA, USA), supplemented with Triton X-100 at a final concentration of 0.01% 
(v/v), reduced to 2 ml and separated by preparative size exclusion chromatography (SEC) (Fig. S1). Fractions cor-
responding to the size of the monomeric α-TTP ligand-complex were pooled and concentrated to 20 mg/ml using 
Vivaspin concentrators (MWCO 10 kDa; Sartorius, Gottingen, DE) and directly used for crystallisation. Fractions 
corresponding to the size of α-TTPS nano-spheres were pooled and concentrated using Vivaspin concentrators 
(MWCO 30 kDa) to 10 mg/ml re-purified by analytical SEC.
Crystallisation and structure determination of α-TTPS. Crystals were grown by either hanging or 
sitting-drop vapour diffusion using reservoir solutions ranging from 10 to 15% PEG-4000, 100–175 mM ammo-
nium sulphate in 100 mM Hepes sodium pH 7.5 at 18 °C. Freshly prepared monomeric α-TTP ligand-complex 
was used in a concentration range between 12–22 mg/ml. Highest quality crystals of fully reduced α-TTPS were 
observed within two weeks at drop ratios of protein over reservoir ranging between 3/1 and 2/1 (v/v). Crystals 
had cubic shape with edge length ranging between 20 and 80 µM. Isomorphous crystals of fully oxidised α-TTPS 
were collected after two months. All crystals were flash frozen in nitrogen after adding glycerol in two steps to 
a final concentration of 20% (v/v). Diffraction data were collected at the Swiss Light Source (SLS) synchrotron 
beamline X06DA (PSI Villigen) at 100 K, employing a Dectris Pilatus 2 M CCD detector (DECTRIS Ltd., Baden, 
Switzerland). All data were indexed, integrated and scaled with XDS65. Phaser-MR was used for calculating the 
initial phases with the truncated structure model (residues 47–275) of monomeric α-TTP (PDB ID: 1OIP) as 
search structure. The atomic models of reduced α-TTPS and of oxidised α-TTPS were both refined by iterative 
cycles of manual model building using COOT66 and restrained refinements using the Phenix program suite67. 
Coordinates and structure factors of both structures have been deposited in the RCSB Protein Data Bank with ID 
codes 5MUE and 5MUG.
Binding energy calculations. The oligomerisation energies were computed for the trimeric and tetrameric 
interfaces using standard thermodynamic solvation/association cycle as described in ref. 68. The solvation energy 
was computed by numerical solution of the Linearized Poisson-Boltzmann equation using APBS69. Both the 
charge distribution and the non-electrostatic part of the binding energy were estimated using the AMBER force 
field parameters described by Maier et al.70.
Size exclusion chromatography. Preparative (Fig. S2B) and analytical SEC (Fig. S1) of α-TTPS oligomers 
was performed on HiLoad 16/60 Superose 75 prep grade and on Superose 6 10/300 columns respectively (GE 
Healthcare, Little Chalfont, UK), both attached to an ÄKTA Purifier chromatography system (GE Healthcare, 
Little Chalfont, UK). Runs were performed in SEC buffer (10 mM Tris, 100 mM NaCl, pH 8.0) at flow rates 
ranging from 0.5 (analytical) to 1.5 ml/minute (preparative) at 6 °C. Both SEC columns were calibrated using 
commercially available protein calibration kits (GE Healthcare, Little Chalfont, UK). MALS experiments were 
performed in 10 mM Tris pH 8.0, 100 mM NaCl, using a Superose 6 Increase 10/300 GL analytical size exclusion 
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chromatography column (GE Healthcare, Little Chalfont, UK) connected in line to mini-DAWN TREOS light 
scattering and Optilab T-rEX refractive index detectors (Wyatt Technology, CA, USA). Monomeric α-TTP was 
injected at a concentration of 485 µM; the oligomeric α-TTPS at a concentration of 36.6 µM.
Negative-stain transmission electron microscopy. A sample of α-TTPS at a concentration of 300 µg/ml 
was adsorbed for 1 minute to parlodion carbon-coated copper grids, which were previously rendered hydrophilic 
by glow discharge at low pressure in air. After adsorption the grids were washed with three drops of double-distilled 
water and stained with two drops of 0.75% uranyl formate. Electron micrographs were recorded with a Philips 
CM12 transmission electron microscope operated at 80 kV and equipped with a Morada CCD camera (Soft Imaging 
System). Image analysis was performed with the ImageJ image processing program V1.49o (NIH, MD, USA).
Native polyacrylamide gel electrophoresis. Native PAGE was performed using pre-cast NativePAGE 
Novex 4–16% Bis-Tris Protein Gels (Life Technologies, CA, USA). Each protein sample (20 µl, 0.5 mg/ml) was 
mixed with an equal volume of native-PAGE loading buffer (62 mM Tris, 25% glycerol, 1% bromophenol blue, pH 
6.8). Gels were run at 4 °C in running buffer (50 mM Tricine, 50 mM BisTris, pH 8.0) at 160 V for 30 minutes and 
then at 180 V until the bromophenol blue marker reached the end of the gel. Protein visualisation was achieved by 
staining with SYPRO ruby protein gel stain (Life Technologies, CA, USA).
Western Blotting. In brief, SDS-PAGE was carried out on 12% PAGE gels. Before blotting on nitrocellulose 
membranes gels were incubated for 20 minutes in transfer buffer (25 mM Tris, 192 mM glycine, 20% metha-
nol, pH 8.3). Blotting was carried out at 130 mA for 50 minutes using a semi-dry blotting apparatus (Bio-Rad 
Laboratories, CA, USA). For analysis a commercially available primary antibody against α-TTP (alpha TTP 
Antibody [C2C3] C-term, GeneTex Inc., CA, USA) was used. IRDye secondary antibodies from LI-COR were 
employed for visualisation with either IRDye 800CW or IRDye 680RD and scans were performed on a LI-COR 
Odyssey infrared system (LI-COR Biosystems, NE, USA) (Fig. S2D).
Dynamic light scattering. Freshly pooled fractions of α-TTP (concentration range 0.1–0.2 mg/ml) 
obtained from analytical SEC (10 mM Tris, 100 mM NaCl, pH 8.0) corresponding to α-TTPS were analysed by 
dynamic light scattering (DLS). Determination of the size distribution profile of each sample was performed on 
a DynaPro molecular sizing instrument (Protein-Solutions) using UVettes® (Eppendorf, Hamburg, DE) of 1 cm 
path length. Each data set was collected for at least 5 minutes containing a minimum of 100 single measurements.
Thermodynamic analysis of α-TTP and α-TTPS. A Jasco J-175 Spectropolarimeter with a Peltier 
PFD-350S temperature controller was used to monitor temperature-depended protein unfolding of apo-α-TTP, 
monomeric α-TTP and of α-TTPS. For this, a 1 mm path length quartz cell (with 100 µl sample) was used, and 
the protein concentration ranged from 0.1–0.5 mg/ml. The response was set to 1 s with a bandwidth of 5 nm. 
Following the results from the CD spectra, the wavelength was adjusted to 222 nm for temperature-dependent 
protein unfolding experiments. The temperature was increased at a rate of 2 K min−1 from 20 °C to 80 °C, for mon-
omeric α-TTP, and from 20 °C to 100 °C, for α-TTPS, both in increments of 0.5 K. The transition temperatures 
(Tm) were calculated from the 1st derivative of the unfolding curves.
Transcytosis. α-TTP fractions corresponding to monomeric and tetracosameric protein from analytic gel 
filtration were labelled with fluorescein isothiocyanate (FITC) according to a method previously described by 
Harlow et al.71. In brief, protein samples were transferred into carbonate buffer (0.1 M, pH 9.0) for labelling using 
PD-10 desalting columns (GE Healthcare, Little Chalfont, UK) previously equilibrated in the same buffer. FITC 
was freshly dissolved before use in anhydrous DMSO (1 mg/ml). The labelling reaction was started by adding 
50 µl of FITC DMSO solution to one ml of protein (1 mg/ml). The reaction mixture was incubated for 2 hours 
at 37 °C and stopped by removing excessive FITC using a PD-10 column previously equilibrated in PBS (10 mM 
phosphate, 138 mM NaCl, 27 mM KCl, pH 7.4). The labelled protein samples were finally purified by analytical 
GFC on a Superose 6 10/300 GL column (GE Healthcare, Little Chalfont, UK) in PBS. Transferrin was labelled 
by the same method and used as positive control in transcytosis experiments. In order to demonstrate promotion 
of transcytosis by α-TTPS oligomers we used primary endothelial cells from human umbilical veins (HUVECs). 
HUVECs were isolated from fresh umbilical cords with the help of trypsin/EDTA according to a Miltenyi Biotec 
protocol72. The authenticity of endothelial origin was verified via positive immunofluorescence co-staining of 
von Willebrand factor (vWF) and CD31. HUVECs were cultured in a transwell system (permeable polyester 
membranes with 0.4 µm pore size; Corning, USA) in Endothelial Cell Growth Medium (Promocell, Germany) 
comprising 100 U/ml penicillin and 100 µg/ml streptomycin (PAN Biotech, Germany) with gelatin pre-coating 
(Sigma-Aldrich, Germany). Cells were allowed to form a tight monolayer within 7 days of culture while medium 
was changed every other day. For transcytosis measurements medium comprising 200 µg of RITC-dextran 70 kDa 
(Sigma Aldrich, MO, USA) and either 200 µg of FITC labelled monomeric α-TTP, oligomeric α-TTPS or trans-
ferrin (as a positive control) was applied to the apical chamber, respectively. Transport was monitored by sam-
pling 100 µl of basolateral medium at various time points (15, 30, 45, 60, 120, 180, and 240 min) after addition 
of samples to the apical chamber. Basolateral aliquots were subsequently analysed for fluorescence with a Tecan 
infinite200 microplate reader (Tecan, Mannedorf, CH) at an excitation wavelength of 485 nm and an emission 
wavelength of 535 nm (FITC) followed by measurements at an excitation wavelength of 535 nm and an emission 
wavelength of 590 nm (RITC), respectively. The Caco-2/TC7 cell line (human colorectal adenocarcinoma cells; 
kindly provided by Dr G. Lietz, Newcastle University, UK) representing an epithelial cell model was used as a neg-
ative control in transcytosis experiments. Caco-2 cells were maintained in Dulbecco,s Modified Eagles Medium 
containing 4.5 g/l glucose, 4 mmol/l L-glutamine, 1 mmol/l sodium pyruvate, 100/ml penicillin, 100 µg/ml 
streptomycin (PAN Biotec, Germany) and 20% (v/v) FCS (Gibco, Germany). Caco-2 cells are widely used as 
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an in vitro model for barrier and transport studies44, 73, 74. Caco-2 cells differentiate and form a tight epithelial 
monolayer in the same transwell system as described above within 14 days of culture. The differentiation process 
of Caco-2 cells is well-characterised and can be measured by various markers: increase in TEER and alkaline 
phosphatase activity, cellular dome formation75, tight junction formation, polarisation, development of apical 
microvilli76 and reduced permeability already within 4 days of differentiation. The Caco-2/TC-7 clone used in this 
study differentiates faster than the parental Caco-2 cell line, observed by a more rapid increase in TEER values77. 
TEER directly correlates with differentiation state as well as barrier tightness of Caco-2 cells78. The higher transe-
pithelial resistance, calculated in Ω/cm2, the higher tightness and the lower paracellular permeability of Caco-2 
cell monolayers, thus, transport remains exclusive for the transcellular route79. Therefore, TEER measurement is 
a suitable, non-invasive method to longitudinally evaluate barrier tightness of Caco-2 cells in response to com-
pounds provided via the apical side of the monolayer resembling the luminal side of the gut. In our experiments, 
differentiation was confirmed by TEER measurements. Caco-2/TC-7 monolayers were cultured for 14 days while 
TEER increased to 388.8 6.1 Ω/cm2 due to the differentiation process. As initial TEER values of confluent, but 
non-differentiated Caco-2/TC-7 monolayers, are averagely classified by 96.4 ± 6.8 Ω/cm2, differentiation process 
was well advanced, indicated by a 403.4 ± 6.3% increase of initial TEER values. Although Caco-2 cells seem to be 
able to absorb tocopherols indicated by influencing stress-activated signal transduction pathways80 bioavailability 
is markedly low81. Thereby tocopherols pass intestinal epithelium solely following transfer into mixed micelles 
and incorporation into chylomicrons for trans-epithelial transport to the lymphatic and blood system82, 83.
Transcytosis experiments were performed according to the HUVEC experiments. The rate of flux was calcu-












The flux is here the slope (cm s−1) of the basolateral fluorescence (Bf) per unit amount of apical fluorescence (Af) 
normalised to the volume of basolateral chamber (Vb) and to the area available for transport (A) against time (t). 
As a control for paracellular flux and as assurance for the formation of tight junctions, rhodamine isothiocyanate 
(RITC) dextran (70 kDa) was added simultaneously to the apical chamber in each experiment as tight junction 
control. The level of paracellular transport by RITC dextran was measured in the same manner as FITC-α-TTP, 
except that the RITC was detected at an excitation wavelength of 545 nm and an emission wavelength of 590 nm 
respectively. The different fluorescence behaviour of RITC and FITC has allowed for the simultaneous analysis of 
the protein of interest and the dextran control. Since dextran is not internalised at appreciable levels by endothelial 
cells, any accumulation of dextran in the basal chamber correlates with paracellular flux. Three independent tran-
scytosis experiments were performed using HUVEC and Caco-2 cell monolayers, respectively.
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